Special clinical nutritional formulation for AIDS (Acquired Immune Deficiency Syndrome) and preparation method thereof

Abstract

The invention provides a special clinical nutritional formulation for AIDS (Acquired Immune Deficiency Syndrome). The special clinical nutritional formulation is prepared from the following componentsin parts by weight: 23 to 32 parts of protein, 13 to 17 parts of fat, 27 to 40 parts of carbohydrate, 10 to 20 parts of dietary fiber, 0.4 to 0.7 part of macro elements, 0.01 to 0.04 part of trace elements, 0.005 to 0.02 part of fat soluble vitamin, 0.1 to 0.25 part of water-soluble vitamin, 0.1 to 4 parts of dietary essence, 0.2 to 2 parts of medicinal and edible ingredients and 0.05 to 4 partsof new resource food. The invention also provides a preparation method of the clinical nutritional formulation. The clinical nutritional formulation provided by the invention has the advantages that the toxic and side effects and adverse reactions of anti-AIDS drugs can be alleviated; corresponding symptoms of the AIDS are relieved from the pathogenesis; the autoimmunity barrier of patients is repaired and the occurrence of opportunistic infection is prevented, so that nutritional auxiliary functions of the special clinical nutritional formulation in clinical treatment are realized.

Description

technical field [0001] The invention relates to the field of clinical nutritional formulas, in particular to an AIDS-specific clinical nutritional formula and a preparation method thereof. Background technique [0002] AIDS, the full name of acquired immunodeficiency syndrome, is a sexually transmitted disease (STD) caused by human immunodeficiency virus infection and characterized by severe immunodeficiency. Clinically, it is characterized by lymphadenopathy, anorexia, chronic diarrhea, weight loss, Onset of systemic symptoms such as fatigue, and gradually developed to various opportunistic infections, secondary tumors, etc. and died. AIDS spreads quickly and has a high fatality rate. Currently, there is no effective cure, and it has become one of the major fatal infectious diseases for human beings. [0003] AIDS (HIV) can be divided into type 1 (HIV-1) and type 2 (HIV-2) according to serotype, among which HIV-1 is the main epidemic type of AIDS, and HIV-2 is mainly limit...

AI Technical Summary

Problems solved by technology

However, the enteral nutrition preparation of this patent is only used to provide routine nutritional support for AIDS patients to improve the nutritional status of patients and enhance the immunity of patients, and does not have the function of nutritional assistance in clinical treatment

[0015] At present, the drug preparations for AIDS are mainly virus blocking drugs and anti-viral replication drugs taken within 72 hours. There are still the following problems: 1. The toxic and side effects of the drugs are relatively strong; 2. The drugs need to be taken for a long time. There are no targeted products for the consumption of various nutrients that can support and supplement the body; 3. There is no nutritional supplement that can provide targeted nutritional support and symptom relief for the clinical manifestations of AIDS.

[0016] Therefore, the development of a clinical nutrition product that can fill the gap that is not yet clear can alleviate the side effects and adverse reactions of anti-HIV drugs, alleviate and improve the corresponding symptoms of AIDS from the perspective of pathogenesis, and at the same time enhance the patient's self-immunity , the clinical nutritional formula for repairing the patient's autoimmune barrier and preventing opportunistic infection has important value and a broad market